INTRODUCTION
Atrial fibrillation (AF) is associated with an increased risk of stroke, congestive heart failure, and all-cause mortality.Reference Stewart, Hart and Hole 1 It is a frequent reason for presenting to the emergency department (ED). In the United States, it accounts for approximately 1% of all ED visits.Reference Barrett, Martin and Storrow 2 The management of this common arrhythmia is challenging. However, before starting a specific treatment it is important to consider why the patient is symptomatic and whether the AF is responsible for the symptoms. Instability might be due to other causes of acute illness like sepsis or gastrointestinal bleeding, and therefore, AF with a high heart rate may be only an epiphenomenon associated with these conditions.
Two competing strategies can be used for the management of recent-onset AF: rate-control or rhythm-control. Both approaches are acceptable according to current guidelines.Reference Stiell and Macle 3 Case series have confirmed the efficacy and safety of the rhythm-control strategy.Reference Ballard, Reed and Singh 4
Nevertheless, a conservative approach of observation may be considered, as up to 60% of patients with recent-onset AF will spontaneously convert to sinus rhythm in the first 24 hours after presentation, making pharmacologic or electrical cardioversion unnecessary.Reference Capucci, Lenzi and Boriani 5 If performed in the ED, cardioversion should be used with caution in higher-risk patients. To mitigate the risk of stroke from embolization of left atrial appendage thrombus, acute cardioversion should only be considered in patients with symptoms of less than 48-hours duration or only after more than three weeks of therapeutic anticoagulation.Reference Stiell and Macle 3
CASE REPORT
An 83-year-old man was admitted to the ED because of increasing shortness of breath and palpitations during the previous weeks. The otherwise hemodynamically stable patient (blood pressure 155/112 mm Hg, heart rate 147 bpm) denied chest pain. Because of paroxysmal AF, the patient was on chronic oral anticoagulation (OAC) therapy with warfarin (international normalized ratio (INR) at admission was 4.1). The use of intravenous beta-blocker (5 mg of metoprolol) was ineffective in reducing his heart rate. Therefore, immediate cardioversion was performed successfully (200 J) and without complications (Figure 1A and 1B). Because of recurrent atrial runs, the patient subsequently received intravenous amiodarone (300 mg). One hour later, the patient reported chest pain. The electrocardiogram (ECG) showed marked ST-segment elevation in the anterior leads (Figure 1C). Urgent cardiac catheterization via right radial artery disclosed an eccentric plaque in the left main coronary artery (LMCA) with TIMI 3 flow (Figure 2A). Quantitative coronary angiography (QCA) revealed stenosis severity of 30%. There were no other significant stenosis in the left or right coronary arteries. Based on the vessels morphology and spontaneous restoration of flow in LMCA, an optical coherence tomography (OCT) was performed. OCT demonstrated an intimal disruption in the LMCA (Figure 2C). Therefore, a Xience V stent (4.0×8 mm) was deployed (Figure 2B). After stent deployment, intracoronary OCT was repeated to evaluate stent placement and expansion. OCT revealed incomplete expansion (Figure 2D) and a second dilatation with a non-compliant balloon was necessary. The final OCT control demonstrated a good result with adequate stent expansion (Figure 2E). The ECG two hours after stenting of the LMCA showed poor R-wave progression but no ST-segment elevation (Figure 1D). High-sensitive cardiac troponin I level (Abbott ARCHITECT STAT high sensitive troponin I immunoassay, Wiesbaden, Germany) peaked at 168 pg/mL (normal, <34.2 pg/mL). Echocardiography revealed a dilated left ventricle (61 mm) with moderate reduced LV function (45%) due to global hypokinesis. Five days after cardioversion, there was a recurrence of AF that was refractory to antiarrhythmic treatment with amiodarone (patient received 1,000 mg oral amiodarone per day in divided doses until a total of 8 g; then 200 mg per day); as per standard guidelinesReference Fuster, Rydén and Cannom 6 . Four weeks later, a biventricular pacemaker was implanted in preparation for the AV node ablation that was successfully performed at four weeks post pacemaker implantation. At this time point, a second attempt for cardioversion was not possible, because transesophageal echocardiography revealed thrombi in the left atrial appendage. Since restoration and maintenance of sinus rhythm was no longer the treatment goal, amiodarone was stopped.
DISCUSSION
This case may have educational value in two ways. First, it demonstrated that immediate cardioversion in a patient with unknown duration of AF should be done cautiously, especially if the patient is in a stable condition. In such cases, immediate cardioversion could be either ineffective in conversion to sinus rhythm or only effective for a short-term period like was the case for our patient. Furthermore, cardioversion may carry the risk of stroke. In our case, subsequent transesophageal echocardiography in preparation for a second attempt of cardioversion disclosed left atrial appendage thrombi despite the assumed effective long-term OAC, and it might have been considered fortunate, therefore, that no stroke occurred following the first cardioversion. Although anecdotal, this case suggests an advantage of rate-control as first-line therapy; as has been suggested, especially in an otherwise stable patient with an estimated higher CHA2DS2-Vasc-Score.Reference Atzema and Barrett 7 If rhythm-control is the chosen therapeutic strategy, transesophageal echocardiography should be performed before cardioversion, even if the patient is believed to be on chronic OAC (especially when it is unknown whether a continuous OAC with target INR 2–3 for at least 3 weeks was indeed ensured).Reference Fuster, Rydén and Cannom 6
Second, there is another interesting aspect in our reported case. ST-segment elevation following cardioversion is a well-known phenomenon. In a case series of 91 patients referred for cardioversion of AF, it was demonstrated that 35% of the patients developed transient ST-segment elevations.Reference Rumeau, Fourcade and Duparc 8 Although several theories have been suggested for these ST-segment elevations, the exact mechanism has not yet been clearly established. Actually, there is no evidence that cardioversion is combined with an increased risk of myocardial infarction. Prior work has shown that cardiac markers usually do not increase after direct current (DC) cardioversion.Reference Rao, Naeem and John 9 Moreover, using myocardial scintigraphy, it has been demonstrated that the ST-segment elevation observed after DC cardioversion does not necessarily indicate myocardial injury.Reference Shan, Lin, Xu and Huang 10 However, in our patient the ST-segment elevation was combined with acute chest pain. Even though the plaque rupture in the LMCA was not flow limiting, the chest pain resolved after immediate percutaneous coronary intervention (PCI).
CONCLUSION
ST-segment changes following DC shock cardioversion of AF are common, but usually short-lived and without clinical significance. Whether the ST-segment elevation in our patient was due to ST-elevation myocardial infarction (STEMI) or just a consequence of the cardioversion is unclear. Furthermore, the relevance of the lesion in the left main coronary artery is also speculative. However, immediate cardiac catheterization is mandatory in patients with ST-elevation and suspicious symptoms (if not otherwise contraindicated).
Competing Interests: None to declare.